Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis. 2003

Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
University of Bristol, Department of Pathology and Microbiology, School of Medical Sciences and Bristol Royal Infirmary, Bristol, UK.

Beta-Catenin is a multifunctional protein originally identified as a component of the cadherin cell-cell adhesion complex. It also binds the adenomatous polyposis coli (APC) tumour suppressor which controls beta-catenin cellular levels through its degradation. (beta-Catenin and/or APC mutations result in increased cytoplasmic Beta-catenin and nuclear translocation. The aim of the present study was to examine the expression and cellular localisation of alpha and beta-catenin, p120 and E-cadherin in a chemically-induced mouse model of colo-rectal cancer using 1,2-dimethylhydrazine (DMH). Female Balb/C mice were injected subcutaneously with a solution providing 25 mg DMH base/kg body weight for 17 weeks. Animals were killed and tumours identified in the intestine with a dissecting microscope. Formalin-fixed paraffin-embedded sections of normal and dysplastic colonic mucosa were stained by an indirect avidin-biotin immunohistochemical technique using mouse monoclonal antibodies, and membranous, cytoplasmic and nuclear cellular localisation was assessed by light microscopy. Staining distribution scored as follows: 3, > 90 % positive epithelial cells; 2, >50 % positive epithelial cells; 1, <50 % positive epithelial cells. Non-dysplastic colonic epithelial cells revealed beta-catenin expression at the membrane (33/41 scored 3),areas of cytoplasmic expression (24/41 scored 1) and no nuclear staining. Dysplastic colonic epithelium revealed increased membranous and cytoplasmic, beta-catenin immunoreactivity (39/41 and 38/41 both scored 3) with focal nuclear staining (14/41). Expression patterns for ac-catenin, p120, and E-cadherin were similar to beta-catenin with increased membranous and cytoplasmic immunoreactivity in dysplastic mucosa, although no nuclear staining was observed. Increased cytoplasmic expression and nuclear localisation of beta-catenin are consistent with a possible mutation in its gene, and this finding was in keeping with the mutational analysis of exon 3 by single-strand conformational polymorphism. Increased immunoreactivity of the other catenins also suggests further disruption in catenin regulation. In summary, alterations in the beta-catenin expression and cellular localisation in the DMH-induced tumours are similar to those seen inhuman sporadic colorectal tumours. The DMH is therefore a useful model for studying the abnormalities of the E-cadherin-catenin pathway in colorectal carcinogenesis.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014178 Translocation, Genetic A type of chromosome aberration characterized by CHROMOSOME BREAKAGE and transfer of the broken-off portion to another location, often to a different chromosome. Chromosomal Translocation,Translocation, Chromosomal,Chromosomal Translocations,Genetic Translocation,Genetic Translocations,Translocations, Chromosomal,Translocations, Genetic
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear

Related Publications

Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
September 1999, Toxicological sciences : an official journal of the Society of Toxicology,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
January 1985, Alcohol and alcoholism (Oxford, Oxfordshire),
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
January 2012, Sub-cellular biochemistry,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
May 2001, Medical hypotheses,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
December 2005, Cell,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
September 2011, European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
February 2003, Oncogene,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
January 1978, Fortschritte der Medizin,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
August 1999, Oncogene,
Emma Tucker, and Andrea Buda, and Baker Janghra, and Joy Cpoad, and Morganden Moorghan, and Mike Havler, and Peter Dettmar, and Massimo Pignatelli
September 2007, Applied immunohistochemistry & molecular morphology : AIMM,
Copied contents to your clipboard!